An interventional study on physicians’ adherence to hypertension guidelines
- Conditions
- Cardiovascular - HypertensionHypertensionPublic Health - Health service research
- Registration Number
- ACTRN12614000641695
- Lead Sponsor
- niversity of Malaya
- Brief Summary
Not available
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- Completed
- Sex
- All
- Target Recruitment
- 555
All primary care physician working at the Primary Care Clinic at the University Malaya Medical Centre (UMMC) who are treating the cohort of patients with hypertension from earlier phase of this study (patient with hypertension for at least a year and have been followed up at the Primary Care Clinic).
Earlier phase of the study is a retrospective review of records and it is not registered as it is not an intervention trial. We have published a paper from earlier phase of the study :
Liew et al.: Statins use is associated with poorer
glycaemic control in a cohort of hypertensive patients with diabetes and without diabetes. Diabetology & Metabolic Syndrome 2014 6:53. doi:10.1186/1758-5996-6-53
All primary care physician working at the Primary Care Clinic at the University Malaya Medical Centre (UMMC) who are not treating the cohort of patients with hypertension from earlier phase of the study
Study & Design
- Study Type
- Interventional
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method Primary outcome is the proportion of patients with controlled blood pressure. Controlled blood pressure is defined as blood pressure less than 140/90mmHg and measured using mercury sphygmomanometer by the doctors. <br>[0 to 3 months post intervention for immediate effect of intervention, 3 to 6 months post intervention for sustainability of intervention]
- Secondary Outcome Measures
Name Time Method The rates of documentation of process indicators and outcome indicators from the checklist provided in the medical records: these include the rate of documentation of process indicators (BP, weight measurement, assessment of cardiovascular risk factors, target organ damage and comorbidities, examinations, investigatory tests ordered) and the rate of documentation of outcome indicators (medication use) [0 to 3 months post intervention for immediate effect of intervention, 3 to 6 months post intervention for sustainability of intervention]